Gene · 23239
Papers1,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-cancer structurome reveals overrepresentation of beta sandwiches and underrepresentation of alpha helical domains. | Sci Rep | 2023 | 37491511 | PubTator, text mining | PubMed |
| Identifying and profiling structural similarities between Spike of SARS-CoV-2 and other viral or host proteins with Machaon. | Commun Biol | 2023 | 37468602 | PubTator, text mining | PubMed |
| Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma. | Front Immunol | 2023 | 37457718 | PubTator, text mining | PubMed |
| The inhibition of FKBP5 protects β-cell survival under inflammation stress via AKT/FOXO1 signaling. | Cell Death Discov | 2023 | 37452039 | PubTator, text mining | PubMed |
| Editorial: Enhanced biological mechanism study, drug discovery and individualized medicine with single-cell multiomics data and integrative analysis. | Front Genet | 2023 | 37434951 | PubTator, text mining | PubMed |
| The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer. | Cell Commun Signal | 2023 | 37430297 | PubTator, text mining | PubMed |
| Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape. | Oncol Res | 2023 | 37415743 | PubTator, text mining | PubMed |
| CMA mediates resistance in breast cancer models. | Cancer Cell Int | 2023 | 37407979 | PubTator, text mining | PubMed |
| Molecular basis of fluoride toxicities: Beyond benefits and implications in human disorders. | Genes Dis | 2023 | 37397522 | PubTator, text mining | PubMed |
| A Systems Biology Approach to Identify Novel Biomarkers in Progression from Crohn's Disease to Colorectal Cancer. | Asian Pac J Cancer Prev | 2023 | 37378929 | PubTator, text mining | PubMed |
| Interactome of Long Non-Coding RNAs: Transcriptomic Expression Patterns and Shaping Cancer Cell Phenotypes. | Int J Mol Sci | 2023 | 37373059 | PubTator, text mining | PubMed |
| Multiplex Protein Imaging through PACIFIC: Photoactive Immunofluorescence with Iterative Cleavage. | ACS Bio Med Chem Au | 2023 | 37363079 | PubTator, text mining | PubMed |
| Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities. | Front Oncol | 2023 | 37342192 | PubTator, text mining | PubMed |
| Identification and preliminary study of a novel interacting protein SCRIB with fibroblast activation protein in OSCC. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37337635 | PubTator, text mining | PubMed |
| Applications of Boolean modeling to study the dynamics of a complex disease and therapeutics responses. | Front Bioinform | 2023 | 37325771 | PubTator, text mining | PubMed |
| Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views. | J Transl Med | 2023 | 37291585 | PubTator, text mining | PubMed |
| Little things with significant impact: miRNAs in hepatocellular carcinoma. | Front Oncol | 2023 | 37274242 | PubTator, text mining | PubMed |
| PROTACs: A novel strategy for cancer drug discovery and development. | MedComm (2020) | 2023 | 37261210 | PubTator, text mining | PubMed |
| A risk signature of ubiquitin-specific protease family predict the prognosis and therapy of kidney cancer patients. | BMC Nephrol | 2023 | 37259026 | PubTator, text mining | PubMed |
| Seeking a better understanding of the non-receptor tyrosine kinase, SRMS. | Heliyon | 2023 | 37251450 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23239/papers?page=7